Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Blumenkranz Insider Profile
4 Followers
Mark Blumenkranz, Director at Adverum Biotechnologies, holds 182.82K shares in Kala Pharmaceuticals (Ticker: KALA), holds 0.00 shares in IVERIC bio (Ticker: ISEE), holds 0.00 shares in 1Life Healthcare (Ticker: ONEM).
Mark Blumenkranz Adverum Biotechnologies (ADVM)Director
Adverum Biotechnologies (ADVM)
Director
Ranked #21,433 out of 99,060 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+106.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Blumenkranz holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 07, 2014 - Aug 07, 2015
Return:+124.10%
The most profitable trade made by Mark Blumenkranz
Mark Blumenkranz's Trading History
Adverum Biotechnologies
Jun 15, 2015
Director
Uninformative Sell
75.92K
$4.17M
1Life Healthcare
Feb 24, 2023
―
Uninformative Sell
81.61K
$0.00
IVERIC bio
Jul 13, 2023
―
Uninformative Sell
―
$0.00
Kala Pharmaceuticals
Jun 12, 2024
Director
Uninformative Buy
―
$955.24K
List of latest transactions for each holding click on a transaction to see Mark Blumenkranz's performance on stock
You May Also Like
Mark Blumenkranz insider profile FAQ
What is the percentage of profitable transactions made by Mark Blumenkranz?
The percentage of profitable transactions made by Mark Blumenkranz is 100%.
What is the average return per transaction made by Mark Blumenkranz?
The average return per transaction made by Mark Blumenkranz is 106.10%.
What stocks does Mark Blumenkranz hold?
Mark Blumenkranz holds: ADVM, ONEM, ISEE, KALA stocks.
What was Mark Blumenkranz’s latest transaction?
Mark Blumenkranz latest transaction was an Uninformative Buy of ―.
What was Mark Blumenkranz's most profitable transaction?
Mark Blumenkranz’s most profitable transaction was an Informative Buy of ADVM stock on August 7, 2014. The return on the trade was 124.10%.
What is Mark Blumenkranz's role in Adverum Biotechnologies?
Mark Blumenkranz's role in Adverum Biotechnologies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.